SCHEMBL22019992

SCHEMBL22019992

Cc1cc(F)c(S(=O)(=O)NC(C)(C)C)s1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.39
HTT P42858 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 6/20 0.37
MAPK1 P28482 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX5AP P20292 8/20 0.36
FEN1 P39748 8/20 0.36
PARG Q86W56 1/20 0.34
GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1548065 0.81 ALDH1A1 (0.40) HPGDSMN1; SMN2LMNAMAPTKDM4E
SCHEMBL16852675 0.80 SMN1; SMN2 (0.36) HPGDHTTNPSR1SMN1; SMN2LMNA
SCHEMBL11459269 0.76 ALDH1A1 (0.61) HPGDHTTNPSR1SMN1; SMN2LMNA
SCHEMBL16377391 0.67 ALDH1A1 (0.46) HPGDSMN1; SMN2LMNAMAPTKDM4E
SCHEMBL1794606 0.67 ALDH1A1 (0.46) HPGDSMN1; SMN2LMNAMAPTKDM4E
SCHEMBL11054324 0.66 KMT2A (0.43) HPGDHTTNPSR1SMN1; SMN2LMNA
SCHEMBL26663815 0.65 MCL1 (0.54) HPGDNPSR1SMN1; SMN2LMNAMAPT
SCHEMBL4972879 0.64 NSD2 (0.41) HPGDSMN1; SMN2LMNAMAPTKDM4E
SCHEMBL21527775 0.64 BRD4 (0.39) HPGDSMN1; SMN2LMNAMAPTKDM4E
SCHEMBL24429412 0.64 CCR2 (0.50) HPGDSMN1; SMN2LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed